Palliative endovascular treatment of cancer-related iliocaval obstructive disease: technical and clinical outcomes
Geert Maleux(Universitair Ziekenhuis Leuven), Raymond Oyen(KU Leuven), Bart Vertenten(KU Leuven), Paul M. Clément(Universitair Ziekenhuis Leuven), Annouschka Laenen(Statistics Belgium), Sam Heye(KU Leuven), Liesbeth De Wever(KU Leuven)
Cited by 20
Related Papers
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
|The Lancet Oncology|2016|504